A comprehensive view of Oral Medicines / Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

TheraBreath releases Immunity Support Oral Spray Supplement; brand says seven sprays of the product once-daily will support the immune system by spraying nutrients and immunity-supporting antioxidants directly to the mouth and throat

Janssen submits NDA to the US FDA seeking approval of niraparib and abiraterone acetate dual-action tablet, plus prednisone, as a first-line targeted treatment for patients with BRCA-positive metastatic castration-resistant prostate cancer

ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva cabotegravir, rilpivirine is as effective as daily oral Biktarvy BIC/FTC/TAF for the treatment of HIV-1

Merck’s Lagevrio oral COVID-19 treatment falls short in clinical trial to prevent infection following household exposure; Lagevrio generated sales of US$5.7B in 2022 as Merck forecasts sales of US$1.0B for the drug this year

Eli Lilly selects Biologics by McKesson as specialty pharmacy provider for Jaypirca pirtobrutinib, an oral treatment for adults with relapsed or refractory mantle cell lymphoma; deal to strengthen McKesson’s foothold in global cancer treatment market

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count